Schlechte Prognose bei Leukämie-Patienten mit Trisomie 13
Ein zusätzliches Chromosom 13 bei der Akuten Myeloischen Leukämie geht mit einem sehr ungünstigen Krankheitsverlauf einh…
Ein zusätzliches Chromosom 13 bei der Akuten Myeloischen Leukämie geht mit einem sehr ungünstigen Krankheitsverlauf einh…
PraenaTest®, Europe's first non-invasive molecular genetic prenatal diagnostic test (NIPT) to determine fetal chromosome…
As Europe’s first non-invasive molecular diagnostic blood test for the determination of fetal chromosomal aneuploidies f…
PrenaTest®, Europe's first non-invasive molecular genetic blood test to determine fetal trisomies 13, 18 and 21 in the m…
In the first three months after market launch, close to 1,000 pregnant women have opted for the PrenaTest®, Europe's fir…
As of today, PrenaTest® is available in more than 70 qualified prenatal diagnostic practices and clinics in Germany, Aus…
LifeCodexx AG today announced the successful completion of the clinical validation study of its noninvasive test method…
GATC Biotech AG and its subsidiary LifeCodexx AG successfully completed the recruitment of over 500 blood samples requir…
NovAliX today announces that it has entered into a multi-year drug research collaboration in the field of trisomy 21 wit…
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced…